Climb Bio Income Statement (2020-2026) | CLYM

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
5.48M5.99M6.88M8.26M8.77M4.26M4.93M5.72M3.69M2.88M3.13M1.09M1.05M6.24M5.96M17.33M6.58M9.07M13.74M9.37M
Selling, General & Administrative (Quarter)
2.91M3.39M3.82M4.87M4.93M4.49M4.63M17.72M3.03M2.12M2.00M1.91M3.67M5.49M4.95M5.69M4.10M5.82M5.56M5.84M
Other Operating Expenses (Quarter)
0.32M0.02M0.06M0.09M0.90M1.11M1.26M1.49M2.79M
Operating Expenses (Quarter)
8.71M9.38M10.70M13.13M13.70M8.75M9.55M23.44M6.71M5.00M5.12M3.00M56.37M11.73M10.91M23.02M10.68M14.89M19.30M15.21M
Operating Income (Quarter)
-8.71M-9.38M-10.70M-13.13M-13.70M-8.75M-9.55M-23.44M-6.71M-5.00M-5.12M-3.00M-56.37M-11.73M-10.91M-23.02M-10.68M-14.89M-19.30M-15.21M
EBIT (Quarter)
-8.71M-9.38M-10.70M-13.13M-13.70M-8.75M-9.55M-23.44M-6.71M-5.00M-5.12M-3.00M-56.37M-11.73M-10.91M-23.02M-10.68M-14.89M-19.30M-15.21M
Non-operating items
Non Operating Investment Income (Quarter)
0.02M-0.10M-0.40M-0.08M0.02M0.22M0.26M0.06M0.02M0.01M0.00M0.20M-0.18M0.26M0.03M0.15M-0.03M-0.28M
Interest & Investment Income (Quarter)
0.15M0.38M0.76M0.90M1.11M1.26M1.35M1.34M1.49M2.79M2.52M2.29M2.17M2.04M1.83M1.51M
Other Non Operating Income (Quarter)
-0.01M-0.23M0.16M-0.16M-0.90M-0.93M1.79M1.15M1.49M1.03M1.48M1.31M-0.00M0.05M-0.03M-0.05M-0.16M-0.03M-0.05M-0.03M
Non Operating Income (Quarter)
1.48M2.84M2.24M2.01M2.00M1.49M
Net income details
EBT (Quarter)
-32.19M-51.11M-31.85M-29.11M-17.49M-12.65M-25.55M-24.98M-7.84M-5.06M-24.63M-2.74M-57.67M-9.88M-8.64M-21.27M-8.54M-14.46M-29.20M-46.05M
Profit After Tax (Quarter)
-8.72M-9.62M-10.67M-13.60M-14.60M-9.68M-7.54M-22.29M-5.22M-3.97M-3.63M-1.70M-54.89M-8.69M-8.62M-20.78M-8.67M-12.89M-17.52M-14.00M
Income from Non-Controlling Interests (Quarter)
-9.63M-10.65M-13.60M
Income from Continuing Operations (Quarter)
-32.19M-51.11M-31.85M-29.11M-17.49M-12.65M-25.55M-24.98M-7.84M-5.06M-24.63M-2.74M-57.67M-9.88M-8.64M-21.27M-8.54M-14.46M-29.20M-46.05M
Consolidated Net Income (Quarter)
-32.19M-51.11M-31.85M-29.11M-17.49M-12.65M-25.55M-24.98M-7.84M-5.06M-24.63M-2.74M-57.67M-9.88M-8.64M-21.27M-8.54M-14.46M-29.20M-46.05M
Income towards Parent Company (Quarter)
-32.19M-51.11M-31.85M-29.11M-17.49M-12.65M-25.55M-24.98M-7.84M-5.06M-24.63M-2.74M-57.67M-9.88M-8.64M-21.27M-8.54M-14.46M-29.20M-46.05M
Preferred Dividend Payments (Quarter)
2.14M1.32M
Net Income towards Common Stockholders (Quarter)
-10.86M-10.94M-10.54M-13.20M-14.60M-9.68M-7.76M-24.98M-7.84M-5.06M-24.63M-2.74M-57.67M-9.88M-8.64M-21.27M-8.54M-14.46M-29.20M-46.05M
Additional items
EPS (Basic) (Quarter)
-3.11-0.70-0.86-0.50-0.56-0.37-0.30-0.94-0.29-0.19-0.91-0.10-1.90-0.15-0.18-0.32-0.13-0.21-0.43-0.68
EPS (Diluted) (Quarter)
-3.11-0.70-0.86-0.50-0.56-0.37-0.30-0.94-0.29-0.19-0.91-0.10-1.90-0.15-0.18-0.32-0.13-0.21-0.43-0.68
Shares Outstanding (Quarter)
3.49M15.59M12.26M26.24M26.30M26.34M26.31M26.49M26.84M27.07M26.99M27.64M30.35M67.01M48.16M67.46M67.59M68.00M67.81M68.21M
Shares Outstanding (Diluted) (Quarter)
3.49M15.59M12.26M26.24M26.30M26.34M26.31M26.49M26.84M27.07M26.99M27.64M30.35M67.01M48.16M67.46M67.59M68.00M67.81M68.21M
EBITDA (Quarter)
-8.71M-9.38M-10.70M-13.13M-13.70M-8.75M-9.55M-23.44M-6.71M-5.00M-5.12M-3.00M-56.37M-11.73M-10.91M-23.02M-10.68M-14.89M-19.30M-15.21M
Interest Expenses (Quarter)
23.48M41.73M21.14M15.97M3.94M4.29M16.76M2.44M2.23M1.32M20.86M1.07M2.79M0.94M0.25M0.53M0.04M1.61M11.73M32.36M